Leaderboards/Cardiomyopathy and Myosin Studies

Cardiomyopathy and Myosin Studies

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Debabrata Dutta
University of Massachusetts Chan Medical School
2
Anne M. Dybro
Aarhus University Hospital
3
Davide Tamborrini
University of Basel
4
Sophie Hespe
Garvan Institute of Medical Research
5
Constantin‐Cristian Topriceanu
University College London
6
Michael Butzner
Cytokinetics (United States)
7
Alessia Argirò
University of Florence
8
Ramin Garmany
Mayo Clinic
9
Karola Jering
Brigham and Women's Hospital
10
Alexander S. Ham
University of Basel

Papers

1
Publication in Journal of the American College of Cardiology (2025) [25 citations, W4406155443]
Journal of the American College of Cardiology|2025
25 cit.
2
Effects of vutrisiran on cardiac structure and function in patients with transthyretin amyloidosis with cardiomyopathy: secondary outcomes of the HELIOS-B trial
Nature Medicine|2025
17 cit.
3
Publication in Nature Reviews Disease Primers (2025) [14 citations, W4413137734]
Nature Reviews Disease Primers|2025
14 cit.
4
Publication in JACC. Cardiovascular imaging (2025) [12 citations, W4410357661]
JACC. Cardiovascular imaging|2025
12 cit.
5
Publication in Journal of Molecular and Cellular Cardiology (2024) [11 citations, W4402341314]
Journal of Molecular and Cellular Cardiology|2024
11 cit.
6
Effects of Vutrisiran on Cardiac Function and Outcomes in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Journal of the American College of Cardiology|2025
10 cit.
7
Publication in European Journal of Human Genetics (2024) [9 citations, W4390611997]
European Journal of Human Genetics|2024
9 cit.
8
Publication in American Journal of Cardiovascular Drugs (2024) [5 citations, W4401794465]
American Journal of Cardiovascular Drugs|2024
5 cit.
9
Publication in BMC Cardiovascular Disorders (2024) [4 citations, W4393053898]
BMC Cardiovascular Disorders|2024
4 cit.
10
Publication in Scientific Reports (2025) [4 citations, W4408930741]
Scientific Reports|2025
4 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Alexandros Protonotarios
The Task Force for Global Health
2
Cynthia Burstein Waldman
New York Heart Research Foundation
3
Luis Aguinaga
Centro Científico Tecnológico - Tucumán
4
Adam Helms
Michigan Medicine
5
J. Travis Hinson
Jackson Laboratory
6
Thomas Deneke
Rhön-Klinikum
7
Krishna G. Aragam
Massachusetts General Hospital
8
Dylan T. Burnette
Vanderbilt University
9
Ethan J. Rowin
Beth Israel Deaconess Medical Center
10
Jon Skinner
The University of Sydney

Papers

1
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
Circulation|2024
616 cit.
2
Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease
JAMA Network Open|2022
440 cit.
3
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases
EP Europace|2022
352 cit.
4
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology|2024
326 cit.
5
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator
European Heart Journal|2022
102 cit.
6
Rare and Common Genetic Variation Underlying the Risk of Hypertrophic Cardiomyopathy in a National Biobank
JAMA Cardiology|2022
78 cit.
7
Blebbisomes are large, organelle-rich extracellular vesicles with cell-like properties
Nature Cell Biology|2025
63 cit.
8
European Heart Rhythm Association (<scp>EHRA</scp>)/Heart Rhythm Society (<scp>HRS</scp>)/Asia Pacific Heart Rhythm Society (<scp>APHRS</scp>)/Latin American Heart Rhythm Society (<scp>LAHRS</scp>) Expert Consensus Statement on the state of genetic testing for cardiac diseases
Journal of Arrhythmia|2022
60 cit.
9
CRISPR Activation Reverses Haploinsufficiency and Functional Deficits Caused by <i>TTN</i> Truncation Variants
Circulation|2024
28 cit.
10
Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Mortality in Hypertrophic Cardiomyopathy
JACC Advances|2024
27 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Christine E. Seidman
Harvard University
2
Barry J. Maron
Lahey Hospital and Medical Center
3
James A. Spudich
Stanford University
4
Stephen E. Epstein
Forma Therapeutics (United States)
5
Perry Elliott
St Bartholomew's Hospital
6
William J. McKenna
British Heart Foundation
7
Hugh Watkins
John Radcliffe Hospital
8
Thomas D. Pollard
Yale University
9
H. Lee Sweeney
University of Florida
10
Richard L. Moss
Emory University

Papers

1
The Regulation of Rabbit Skeletal Muscle Contraction
Journal of Biological Chemistry|1971
4.5k cit.
2
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
European Heart Journal|2014
4.3k cit.
3
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
European Heart Journal|2013
3.4k cit.
4
Contemporary Definitions and Classification of the Cardiomyopathies
Circulation|2006
3.4k cit.
5
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
European Heart Journal|2007
3k cit.
6
Abnormal Endothelium-Dependent Vascular Relaxation in Patients with Essential Hypertension
New England Journal of Medicine|1990
2.4k cit.
7
Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults
Circulation|1995
2.3k cit.
8
Sudden Deaths in Young Competitive Athletes
Circulation|2009
2.1k cit.
9
Single myosin molecule mechanics: piconewton forces and nanometre steps
Nature|1994
1.9k cit.
10
Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology.
Heart|1994
1.7k cit.

Reagents for Cardiomyopathy and Myosin Studies

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Bio-RadEvidence 68

Quick Start Bradford Protein Assay Kit 1

#5000201
View Evidence →

⭐ Top Rated

Best all-around

AbcamEvidence 60

Anti-dystrophin antibody - rabbit polyclonal (ab15277)

Cited in 8 papers
#AB15277$145
View Evidence →
Cell Signaling TechnologyEvidence 66

VDAC Antibody

Cited in 6 papers
#4866$135,314
View Evidence →
Cell Signaling Technology

Protor-2 (D19A5) Rabbit Monoclonal Antibody

Cited in 5 papers
#12288$161,351
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 65

BATF (F2L7C) Rabbit Monoclonal Antibody

Cited in 14 papers
#30889$178,415
View Evidence →
Sigma-Aldrich

Monoclonal Anti-Actin (alpha-Sarcomeric) antibody produced in mouse

Cited in 11 papers
#A2172
View Evidence →
Sigma-AldrichEvidence 63

Monoclonal Anti-alpha-Actinin (Sarcomeric) antibody produced in mouse

Cited in 9 papers
#A7811
View Evidence →